Nitrofurazone | Interleukin Related interleukin-related.com

Product Name :
Nitrofurazone

Search keywords :
Nitrofurazone

drugId :
null

Target Vo:
Pyruvate synthase

Target Vo Short Name :
PFOR

Moa_Name:
Pyruvate synthase inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
1981

Origin Company_Name :

Active Company_Name :
Huangshi Yanwu Pharmaceutical Co Ltd

Active Indication_Name:
Hemorrhage

In Active Indication_Name:
Skin Diseases, Bacterial

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Hsp90 beta Antibody
NLRP3 Antibody
CD38 Antibody: CD38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to CD38. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts